Navigation Links
KGI Announces BIO President Greenwood to Address Health Care Reform and the Presidential Race at Simon Ramo Lecture
Date:2/12/2008

CLAREMONT, Calif., Feb. 12 /PRNewswire/ -- Keck Graduate Institute (KGI) today announced that James Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), will discuss "The American Health Care System & the Presidential Race: Who Will Regulate, Who Will Innovate?" at the 7th Annual Simon Ramo Distinguished Lecture Series on Wednesday, March 26, 2008, at 4 pm.

"We are thoroughly delighted that Jim Greenwood will serve as our guest speaker at this year's event," said Sheldon Schuster, Ph.D., KGI's president. "Health care reform is one of the most pressing issues facing our country. How it is addressed will affect all of us. The Simon Ramo Lecture is an example of KGI's commitment to provide important insights into the world of biotechnology and health care. Because KGI combines science and business to educate tomorrow's leaders in the life sciences, it is critical that we understand how federal policy may affect both. Jim's leadership at BIO and his experience with health care legislation on Capitol Hill give him a unique view of the reform process and the platforms of each candidate."

Greenwood joined BIO in January 2005 after representing Pennsylvania's Eighth District in the U.S. House of Representatives from 1993 to 2005. A senior member of the Energy and Commerce Committee, he was widely viewed as a leader on health care and the environment. Before joining Congress, Greenwood served six years in the Pennsylvania General Assembly (1980-86) and six years in the Pennsylvania Senate (1986-1993).

BIO represents more than 1,150 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. BIO also produces the annual BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

The Simon Ramo Distinguished Lecture Series is KGI's premier annual event showcasing achievements in the life sciences by some of the world's top scientists and business leaders. Previous speakers include J. Craig Venter, Donald Kennedy, Leroy Hood, Maxine Singer, Dr. Bruce Alberts and P. Roy Vagelos. The event is made possible by generous endowment gifts from Simon and Virginia Ramo and the W.M. Keck Foundation.

The lecture is free and open to the public and will take place in the 517 Lecture Hall on the KGI campus. To attend the event, call 909/607-7892 or email events@kgi.edu by March 17.

SIMON RAMO BACKGROUND

Dr. Simon Ramo is a co-founder of TRW Inc., one of the world's largest technological corporations. He was chief scientist in the development of the U.S. Intercontinental Ballistic Missile and chaired the President's Committee on Science and Technology under President Ford. He served as a member of the advisory council to the U.S. Secretary of State on Science and Foreign Affairs, the National Science Board, the Council of Scholars in the Library of Congress, and the White House Council on Energy Research and Development. In addition to the Presidential Medal of Freedom and the NASA Distinguished Public Service medals, Ramo has received the National Medal of Science and the 1999 National Air and Space Museum Trophy for Lifetime Achievement. Ramo serves as a senior advisor to Keck Graduate Institute.

KGI BACKGROUND

Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education through its Master of Bioscience (MBS) degree program and its Ph.D. program in Applied Life Sciences. Using team-based learning and real-world projects, KGI's innovative curriculum seamlessly combines applied life sciences, bioengineering, bioethics and business management. KGI also has a robust research program concentrating on the translation of basic discoveries in the life sciences into applications that can benefit society. KGI is a member of The Claremont Colleges, located in Claremont, California.

Keck Graduate Institute of Applied Life Sciences is dedicated to education and research aimed at translating into practice, for the benefit of society, the power and potential of the life sciences.


'/>"/>
SOURCE Keck Graduate Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
2. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
3. PAREXEL International Announces 2-For-1 Stock Split
4. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
5. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
6. AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
7. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
8. Genta Announces Common Stock Offering of Approximately $3.1 Million
9. Chakshu Research Announces Appointment of Dr. Randall Olson as Director
10. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
11. Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental ... samples to full-size tissues, bones, even whole organs to implant in people to ... blood deep into the developing tissue. , Current bioengineering techniques, including 3-D ...
(Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):